Global Congenital Heart Disease Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Congenital Heart Disease Revenue
• 1.4 Market by Type
  • 1.4.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Medications
  • 1.4.3 Implantable heart devices
  • 1.4.4 Catheter procedures
  • 1.4.5 Open-heart surgery
  • 1.4.6 Heart transplant
• 1.5 Market by Application
  • 1.5.1 Global Congenital Heart Disease Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and clinics
  • 1.5.3 Diagnostic centres
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Congenital Heart Disease Market Perspective (2015-2026)
• 2.2 Global Congenital Heart Disease Growth Trends by Regions
  • 2.2.1 Congenital Heart Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Congenital Heart Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Congenital Heart Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Congenital Heart Disease Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Congenital Heart Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Congenital Heart Disease Players by Market Size
  • 3.1.1 Global Top Congenital Heart Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Congenital Heart Disease Market Concentration Ratio
  • 3.2.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2019
• 3.3 Congenital Heart Disease Key Players Head office and Area Served
• 3.4 Key Players Congenital Heart Disease Product Solution and Service
• 3.5 Date of Enter into Congenital Heart Disease Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Congenital Heart Disease Historic Market Size by Type (2015-2020)
• 4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Congenital Heart Disease Market Size by Application (2015-2020)
• 5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Congenital Heart Disease Market Size (2015-2020)
• 6.2 Congenital Heart Disease Key Players in North America (2019-2020)
• 6.3 North America Congenital Heart Disease Market Size by Type (2015-2020)
• 6.4 North America Congenital Heart Disease Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Congenital Heart Disease Market Size (2015-2020)
• 7.2 Congenital Heart Disease Key Players in Europe (2019-2020)
• 7.3 Europe Congenital Heart Disease Market Size by Type (2015-2020)
• 7.4 Europe Congenital Heart Disease Market Size by Application (2015-2020)

8 China

• 8.1 China Congenital Heart Disease Market Size (2015-2020)
• 8.2 Congenital Heart Disease Key Players in China (2019-2020)
• 8.3 China Congenital Heart Disease Market Size by Type (2015-2020)
• 8.4 China Congenital Heart Disease Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Congenital Heart Disease Market Size (2015-2020)
• 9.2 Congenital Heart Disease Key Players in Japan (2019-2020)
• 9.3 Japan Congenital Heart Disease Market Size by Type (2015-2020)
• 9.4 Japan Congenital Heart Disease Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Congenital Heart Disease Market Size (2015-2020)
• 10.2 Congenital Heart Disease Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Congenital Heart Disease Market Size by Type (2015-2020)
• 10.4 Southeast Asia Congenital Heart Disease Market Size by Application (2015-2020)

11 India

• 11.1 India Congenital Heart Disease Market Size (2015-2020)
• 11.2 Congenital Heart Disease Key Players in India (2019-2020)
• 11.3 India Congenital Heart Disease Market Size by Type (2015-2020)
• 11.4 India Congenital Heart Disease Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Congenital Heart Disease Market Size (2015-2020)
• 12.2 Congenital Heart Disease Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Congenital Heart Disease Market Size by Type (2015-2020)
• 12.4 Central & South America Congenital Heart Disease Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Diagnostics
  • 13.1.1 Abbott Diagnostics Company Details
  • 13.1.2 Abbott Diagnostics Business Overview
  • 13.1.3 Abbott Diagnostics Congenital Heart Disease Introduction
  • 13.1.4 Abbott Diagnostics Revenue in Congenital Heart Disease Business (2015-2020))
  • 13.1.5 Abbott Diagnostics Recent Development
• 13.2 Array BioPharma
  • 13.2.1 Array BioPharma Company Details
  • 13.2.2 Array BioPharma Business Overview
  • 13.2.3 Array BioPharma Congenital Heart Disease Introduction
  • 13.2.4 Array BioPharma Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.2.5 Array BioPharma Recent Development
• 13.3 AstraZeneca
  • 13.3.1 AstraZeneca Company Details
  • 13.3.2 AstraZeneca Business Overview
  • 13.3.3 AstraZeneca Congenital Heart Disease Introduction
  • 13.3.4 AstraZeneca Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.3.5 AstraZeneca Recent Development
• 13.4 Becton Dickinson
  • 13.4.1 Becton Dickinson Company Details
  • 13.4.2 Becton Dickinson Business Overview
  • 13.4.3 Becton Dickinson Congenital Heart Disease Introduction
  • 13.4.4 Becton Dickinson Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.4.5 Becton Dickinson Recent Development
• 13.5 BG Medicine
  • 13.5.1 BG Medicine Company Details
  • 13.5.2 BG Medicine Business Overview
  • 13.5.3 BG Medicine Congenital Heart Disease Introduction
  • 13.5.4 BG Medicine Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.5.5 BG Medicine Recent Development
• 13.6 Bio-Rad
  • 13.6.1 Bio-Rad Company Details
  • 13.6.2 Bio-Rad Business Overview
  • 13.6.3 Bio-Rad Congenital Heart Disease Introduction
  • 13.6.4 Bio-Rad Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.6.5 Bio-Rad Recent Development
• 13.7 Boston Scientific
  • 13.7.1 Boston Scientific Company Details
  • 13.7.2 Boston Scientific Business Overview
  • 13.7.3 Boston Scientific Congenital Heart Disease Introduction
  • 13.7.4 Boston Scientific Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.7.5 Boston Scientific Recent Development
• 13.8 Covance
  • 13.8.1 Covance Company Details
  • 13.8.2 Covance Business Overview
  • 13.8.3 Covance Congenital Heart Disease Introduction
  • 13.8.4 Covance Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.8.5 Covance Recent Development
• 13.9 Critical Diagnostics
  • 13.9.1 Critical Diagnostics Company Details
  • 13.9.2 Critical Diagnostics Business Overview
  • 13.9.3 Critical Diagnostics Congenital Heart Disease Introduction
  • 13.9.4 Critical Diagnostics Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.9.5 Critical Diagnostics Recent Development
• 13.10 Roche
  • 13.10.1 Roche Company Details
  • 13.10.2 Roche Business Overview
  • 13.10.3 Roche Congenital Heart Disease Introduction
  • 13.10.4 Roche Revenue in Congenital Heart Disease Business (2015-2020)
  • 13.10.5 Roche Recent Development
• 13.11 GSK
  • 10.11.1 GSK Company Details
  • 10.11.2 GSK Business Overview
  • 10.11.3 GSK Congenital Heart Disease Introduction
  • 10.11.4 GSK Revenue in Congenital Heart Disease Business (2015-2020)
  • 10.11.5 GSK Recent Development
• 13.12 Janssen Pharmaceuticals
  • 10.12.1 Janssen Pharmaceuticals Company Details
  • 10.12.2 Janssen Pharmaceuticals Business Overview
  • 10.12.3 Janssen Pharmaceuticals Congenital Heart Disease Introduction
  • 10.12.4 Janssen Pharmaceuticals Revenue in Congenital Heart Disease Business (2015-2020)
  • 10.12.5 Janssen Pharmaceuticals Recent Development
• 13.13 Medtronic
  • 10.13.1 Medtronic Company Details
  • 10.13.2 Medtronic Business Overview
  • 10.13.3 Medtronic Congenital Heart Disease Introduction
  • 10.13.4 Medtronic Revenue in Congenital Heart Disease Business (2015-2020)
  • 10.13.5 Medtronic Recent Development
• 13.14 Merck
  • 10.14.1 Merck Company Details
  • 10.14.2 Merck Business Overview
  • 10.14.3 Merck Congenital Heart Disease Introduction
  • 10.14.4 Merck Revenue in Congenital Heart Disease Business (2015-2020)
  • 10.14.5 Merck Recent Development
• 13.15 Mylan
  • 10.15.1 Mylan Company Details
  • 10.15.2 Mylan Business Overview
  • 10.15.3 Mylan Congenital Heart Disease Introduction
  • 10.15.4 Mylan Revenue in Congenital Heart Disease Business (2015-2020)
  • 10.15.5 Mylan Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer